By health condition
By demographic
Each summary is provided by the external research team. The views expressed may not reflect those of the NIHR BioResource.
We’ve also created a few study collections:
Studies 253-261 of 422
King’s Health Partners - Long-COVID19 biomarker study
Speciality areaInfection, COVID
Study typeParticipant re-contact
Researcher typeAcademic
Research leadDr Timothy Nicholson
Analysis of the role of HLA-type on T-cell state in Covid-19 infection
Speciality areaInfection, Genomics and Rare Diseases
Study typeData only
Research leadSoumya Raychaudhuri
Analysis of Structural Variants in 15,370 Individuals from the NIHR BioResource and Integration with Large-Scale Rare Disease Cohorts
Speciality areaGenomics and Rare Diseases
Research leadDr Alba Sanchis-Juan
Studying Stem Cell Gene Therapy for NOD2-associated Crohn's Disease
Speciality areaGastroenterology
Researcher typeCommercial
Research leadDr Pervinder Sagoo
Defining the impact of IL2RA genetic polymorphism on human immune cell function in ulcerative colitis
Research leadDr Peter Irving
A pilot clinical study on the beta prototype of GlyHealth-IBD – a blood test for monitoring current, and predicting future, gut inflammation in patients with inflammatory bowel disease (IBD).
Study typeSamples and data
Research leadDaryl L. Fernandes
Antibody responses to AZD-1222 immunisation
Research leadMichelle Linterman, William Foster
Investigation of a visual colour-change test for detecting SARS-CoV-2 infection in patient samples
Research leadProfessor Anne E Willis
Anti-interferon autoantibodies in COVID-19
Research leadKenneth Smith